SMYD2 promotes cervical cancer growth by stimulating cell proliferation

BACKGROUND: Cervical cancer is the most common gynecological malignancy with low terminal cure rate, and therefore new therapeutic targets are urgently needed to combat this disease. SMYD2, as an oncogene, is abnormal highly expressed in multiple types of tumors and further affects the occurrence an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jun-Jie, Li, Hong-Lin, Ma, Hui, Shi, Yang, Yin, Li-Rong, Guo, Su-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749660/
https://www.ncbi.nlm.nih.gov/pubmed/31548876
http://dx.doi.org/10.1186/s13578-019-0340-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749660/
https://www.ncbi.nlm.nih.gov/pubmed/31548876
http://dx.doi.org/10.1186/s13578-019-0340-9

Ejemplares similares